# Safety and Efficacy of an Intrastromal Transform™ Corneal Allograft (TCA) for Presbyopia Correction

> **NCT03671135** · NA · TERMINATED · sponsor: **Allotex, Inc.** · enrollment: 121 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **OTHER:** TCA Intrastromal Inlay

## Key facts

- **NCT ID:** NCT03671135
- **Lead sponsor:** Allotex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-09
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 121 (ACTUAL)
- **Why stopped:** COVID-19
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03671135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03671135, "Safety and Efficacy of an Intrastromal Transform™ Corneal Allograft (TCA) for Presbyopia Correction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03671135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*